Therapeutic effects of miR-150-5p inhibition on ox-LDL-induced pyroptosis in RAW264.7 macrophages. حسب Ping-yu Cai (12389929)

Therapeutic effects of miR-150-5p inhibition on atherosclerotic lesion development. حسب Ping-yu Cai (12389929)

Data. حسب Melese Bahiru Tesema (19864895)

"…Improving job satisfaction is vital for better healthcare services. However, information on the level of job satisfaction among health professionals in Ethiopia remains scarce. …"

Dysregulation of miR-150-5p and its target FoxO3a in atherosclerosis (AS). حسب Ping-yu Cai (12389929)

Percentage survival of <i>Acinetobacter baumannii</i> infected <i>Galleria mellonella.</i> حسب Techit Thavorasak (13138440)

IFA did not affect LPS-induced inflammation response. حسب Tingting Wang (123983)

IFA treatment facilitated host immune clearance of hypervirulent <i>K</i>. <i>pneumoniae</i> by targeting capsule. حسب Tingting Wang (123983)

IFA effectively limited bacterial dissemination and protected mice from lethal hypervirulent <i>K</i>. <i>pneumoniae</i> pneumonia. حسب Tingting Wang (123983)

IFA reduced the virulence of hypervirulent <i>K</i>. <i>pneumoniae</i> in <i>G</i>. <i>mellonella</i> larvae. حسب Tingting Wang (123983)

IFA reduced the capsular biosynthesis through altering bacterial metabolism. حسب Tingting Wang (123983)

IFA effectively reduced the production of <i>K</i>. <i>pneumoniae</i> capsule. حسب Tingting Wang (123983)

IFA disarmed capsule-mediated immune evasion. حسب Tingting Wang (123983)

IFA abrogated capsule-associated hypermucoviscosity phenotypes of hypervirulent <i>K</i>. <i>pneumoniae</i>. حسب Tingting Wang (123983)

IFA sensitized hypervirulent <i>K</i>. <i>pneumoniae</i> to complement-mediated killing by inhibiting capsule. حسب Tingting Wang (123983)

Validation of distinct contribution of capsule and hypercapsule-associated HMV in IFA-conferred protection against hvKP infection using a <i>ΔrmpD</i>-K7 mutant. حسب Tingting Wang (123983)

Histogram of the extracted parameters. حسب Qiuyu Du (20760848)

"…No significant associations were found with long-term outcomes.…"

Fig 5 - حسب Varun Tiwari (9258130)

Effect of DM, and/or <i>M. charantia</i> on the (I) number of corpuses lutea; (II) number of neonates, (III) weight of neonates; (IV) length of neonates levels in the control and d... حسب Amoura M. Abou-El-Naga (21001524)

Effect of DM, and/or <i>M. charantia</i> on the (I) glucose; (II) HOMA IR, (III) QUICKI levels; (IV) GLUT4; (V) AMPK; (VI) insulin; (VII) leptin levels in the control and different... حسب Amoura M. Abou-El-Naga (21001524)

Effect of DM, and/or <i>M. charantia</i> on the neurotransmitters levels, acetylcholine (I) and dopamine (II). حسب Amoura M. Abou-El-Naga (21001524)